Nvidia (NVDA) Stock: Three Bullish Signals Emerge This Week
Nvidia stock: NVDA shares rise as J.P. Morgan sees options opportunity, Bernstein keeps Outperform rating, and company acquires Sc...
PYTH Price Poised for Upside as Bullish Wedge Approaches Breakout
TLDR: PYTH’s daily chart shows a falling wedge, signaling potential bullish reversal above $0.06. Price compression and reduced se...
Sui Price Dips 6% After 4H 200MA Rejection: Is $1.80 Still in Play?
TLDR Sui price fell 6.63% in the past 24 hours, continuing a weekly decline now exceeding 8% from earlier highs. The token showed...
Is a December Liquidity Shock the Last Obstacle Before a 2026 Crypto Rally?
TLDR Japan’s expected rate hike could trigger rapid crypto and stock liquidations worldwide. Past BOJ hikes caused Bitcoin drops o...
Altcoins Lag Russell 2000 Despite Parabolic Risk Appe
TLDR Altcoins have not mirrored the Russell 2000’s parabolic gains in recent market trends. Direct momentum signals within altcoin...
Altcoins Lag Russell 2000 Despite Parabolic Risk Appetite
TLDR Altcoins have not mirrored the Russell 2000’s parabolic gains in recent market trends. Direct momentum signals within altcoin...
Nvidia (NVDA) Stock Climbs Higher as Chip Giant Launches New Open-Source AI Mode...
TLDR Nvidia launched third-generation Nemotron open-source AI models, with Nemotron 3 Nano available now and two larger versions c...
ServiceNow (NOW) Stock Drops as $7 Billion Armis Buyout Emerges
ServiceNow stock: Shares declined after reports of a potential $7 billion Armis acquisition raised concerns about deal size and ri...
Milestone Pharmaceuticals (MIST) Stock: Wild Price Swings Follow FDA Approval De...
Milestone Pharmaceuticals stock: Trading volatility surges after FDA approval of CARDAMYST as investors scrutinize commercial stra...
Radiopharm Theranostics (RADX) Stock Explode 200% After Brain Cancer Trial Break...
RADX stock: Radiopharm Theranostics shares jump 200% on positive Phase 2b brain metastases trial data showing 92% concordance with...